9 Results for "

PROTAC ERRα Degrader1

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "PROTAC ERRα Degrader1" in MCE Product Catalog:

Cat. No.: HY-128838
CAS No.: 2306388-84-9
Purity:  98.22%
Research Areas:  

Cancer

PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRα Degrader-1 is an PROTAC estrogen-related receptor alpha (ERRa) degrader .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128838A
Purity:  98.18%
Research Areas:  

Others

(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1. PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRα Degrader-1 is an estrogen-related receptor alpha (ERRa) degrader .
loading...
    loading...
Cat. No.: HY-136187A
CAS No.: 2415256-20-9
Purity:  97.8%
Synonyms: VH032-C5-NH2 dihydrochloride
Research Areas:  

Cancer

(S,R,S)-AHPC-C5-NH2 (VH032-C5-NH2) dihydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used for estrogen-related receptor α (ERRα) PROTAC degrader .
loading...
    loading...
Cat. No.: HY-130499
Purity:  98.78%
Research Areas:  

Cancer

ERRα Ligand-Linker Conjugates 1 incorporates a ligand for estrogen-related receptor alpha (ERRα), and a PROTAC linker, which recruit E3 ligases MDM2. ERRα Ligand-Linker Conjugates 1 can be used in the synthesis of a series of PROTACs, such as PROTAC ERRalpha Degrader-1 (HY-128838). PROTAC ERRalpha Degrader-1 is an ERRα degrader .
loading...
    loading...
Cat. No.: HY-128839
CAS No.: 2306388-85-0
Research Areas:  

Cancer

PROTAC ERRα Degrader-2 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRα Degrader-2 is an estrogen-related receptor alpha (ERRa) degrader .
loading...
    loading...
Cat. No.: HY-136186
CAS No.: 2306389-04-6
Synonyms: VH032-C7-amine
Research Areas:  

Cancer

(S,R,S)-AHPC-C7-amine (VH032-C7-amine) is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used for estrogen-related receptor α (ERRα) PROTAC degrader .
loading...
    loading...
Cat. No.: HY-136186B
CAS No.: 2502189-41-3
Synonyms: VH032-C7-amine hydrochloride
Research Areas:  

Cancer

(S,R,S)-AHPC-C7-amine (VH032-C7-amine) hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used for estrogen-related receptor α (ERRα) PROTAC degrader .
loading...
    loading...
Cat. No.: HY-136187
CAS No.: 2170695-19-7
Synonyms: VH032-C5-NH2
Research Areas:  

Cancer

(S,R,S)-AHPC-C5-NH2 (VH032-C5-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used for estrogen-related receptor α (ERRα) PROTAC degrader .
loading...
    loading...
Cat. No.: HY-136186A
CAS No.: 2415256-17-4
Synonyms: VH032-C7-amine dihydrochloride
Research Areas:  

Cancer

(S,R,S)-AHPC-C7-amine dihydrochloride is the dihydrochloride form of (S,R,S)-AHPC-C7-amine (HY-136186). (S,R,S)-AHPC-C7-amine is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker. (S,R,S)-AHPC-C7-amine can be used for estrogen-related receptor α (ERRα) PROTAC degrader .
loading...
    loading...